# Abvc Biopharma, Inc.: Form 8-K, filed Mar 27, 2026

- Company: [Abvc Biopharma, Inc.](/companies/abvc.md) (CIK 1173313)
- Form: 8-K
- Filed: 2026-03-27
- Accepted by EDGAR: Mar 27, 2026, 16:05 ET
- Period: 2026-03-27
- Accession: 0001213900-26-035499
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1173313/000121390026035499/ea028361801-8k_abvcbiopharm.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1173313/000121390026035499/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1173313/000121390026035499/ea028361801-8k_abvcbiopharm.htm

Filed Mar 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-035499. Last ingested by Listed: Nov 2, 2026, 09:52 ET. No prices; not investment advice.